Walgreens Boots Alliance (NASDAQ:WBA) Releases FY25 Earnings Guidance

by · The Cerbat Gem

Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) issued an update on its FY25 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $1.40-$1.80 for the period, compared to the consensus estimate of $1.52. Walgreens Boots Alliance also updated its FY 2025 guidance to 1.400-1.800 EPS.

Walgreens Boots Alliance Trading Up 27.5 %

NASDAQ:WBA opened at $11.76 on Friday. Walgreens Boots Alliance has a 12 month low of $8.08 and a 12 month high of $24.93. The firm has a fifty day simple moving average of $9.26 and a 200-day simple moving average of $9.89. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $10.15 billion, a P/E ratio of -1.17, a PEG ratio of 1.36 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the previous year, the firm posted $0.66 earnings per share. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. On average, equities research analysts anticipate that Walgreens Boots Alliance will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were given a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 8.50%. Walgreens Boots Alliance’s dividend payout ratio is presently -9.99%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on WBA. Evercore ISI lifted their price objective on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a report on Wednesday, October 16th. TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, October 22nd. Morgan Stanley cut their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. Royal Bank of Canada cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a report on Wednesday, December 4th. Finally, UBS Group boosted their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $12.58.

Read Our Latest Stock Report on Walgreens Boots Alliance

Walgreens Boots Alliance Company Profile

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More